Table 1.
Laboratory findings from the admission
| Urinalysis | Biochemistry, immunological, virologic, and coagulation parameters | ||||
|---|---|---|---|---|---|
| Protein | 3+ | TP | 6.9 g/dL | Ferritin | 499 ng/mL |
| Occult blood | 3+ | Alb | 3.3 g/dL | IgG | 1,674 mg/dL |
| Red blood cells | > 100/HPF | UA | 8.3 mg/dL | IgA | 296 mg/dL |
| Protein | 5.72 g/gCr | BUN | 134.2 mg/dL | IgM | 69 mg/dL |
| NGAL | 1485 ng/mL | Cr | 13.96 mg/dL | C3 | 79 mg/dL |
| NAG | 17.8 U/L | eGFR | 3 mL/min/1.73 m2 | C4 | 27.3 mg/dL |
| α1MG | 91.8 mg/L | TB | 0.1 mg/dL | CH50 | 43 U/mL |
| β2MG | 37,676 µg/L | AST | 6 IU/L | Antinuclear Ab | 1:40 |
| Bence Jones protein | – | ALT | 10 IU/L | Anti-dsDNA Ab | – |
| Complete blood cell count | ALP | 249 IU/L | Anti-smith Ab | – | |
| White blood cells | 6,300/µL | γ-GT | 16 IU/L | Anti-CL-β2GP1 Ab | – |
| Neutrophils | 75.10 % | LDH | 166 IU/L | Direct Coombs test | – |
| Lymphocytes | 13.30 % | CK | 64 IU/L | Anti-MPO-ANCA | 1,700 IU/mL |
| Monocytes | 5.90 % | Na | 134 mEq/L | Anti-PR3-ANCA | – |
| Eosinophils | 5.20 % | K | 6.3 mEq/L | Cryoglobulin | – |
| Red blood cells | 238 × 104/µL | Cl | 102 mEq/L | HIV Ag/Ab | – |
| Hemoglobin | 7.5 g/dL | cCa | 7.7 mg/dL | HBs Ag/HBc Ab | – |
| Hematocrit | 22.60 % | IP | 7.3 mg/dL | HCV Ab | – |
| Platelets | 15.8 × 104/µL | CRP | 2.47 mg/dL | PT | 94 % |
| TC | 147 mg/dL | APTT | 24.9 s | ||
| TG | 220 mg/dL | D-dimer | 4.1 µg/mL | ||
| HbA1c | 5.40 % | ||||
| HANP | 340.6 pg/mL | ||||
| BNP | 140.0 pg/mL | ||||
NAG N-acetyl-beta-D-glucosaminidase, NAGL NAG ligand, α1MG alpha1-microglobulin, β2MG beta2-microglobulin, TP total protein, Alb albumin, UA uric acid, BUN blood urea nitrogen, Cr creatinine, eGFR estimated glomerular filtration rate, AST aspartate transaminase, ALT alanine transaminase, ALP alkaline phosphatase, γ-GT gamma-glutamyl transferase, LDH lactate dehydrogenase, CK creatine kinase, CRP C-reactive protein, TC total cholesterol, TG triglycerides, HBa1c glycated hemoglobin, BNP brain natriuretic peptide, ANCA anti-neutrophil cytoplasmic autoantibody, HIV human immunodeficiency virus, PT prothrombin time, APTT activated partial thromboplastin time